Karyopharm Therapeutics Inc. (NASDAQ: KPTI) today announced the pricing of its previously announced registered underwritten public offering of 9,152,543 shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Karyopharm Therapeutics Announces Pricing of Public Offering of Common StockMay 2, 2018 9:45 PM Karyopharm Therapeutics (KPTI) PT Raised to $25 at Cantor FitzgeraldMay 2, 2018 3:48 AM Karyopharm Therapeutics (KPTI) Commences $125M Common Stock OfferingMay 1, 2018 4:41 PM Karyopharm Therapeutics (KPTI) PT Raised to $21 at WedbushMay 1, 2018 9:59 AM Karyopharm Therapeutics (KPTI) PT Raised to $24 at RBC Capital; 'We Would Be Buyers'May 1, 2018 7:58 AM Karyopharm Therapeutics (KPTI) PT Raised to $24 at Leerink PartnersMay 1, 2018 1:34 AM